DnaJB12 Inhibitors
Chemical inhibitors of DnaJB12 can achieve functional inhibition through their impact on the heat shock protein 90 (Hsp90) molecular chaperone, with which DnaJB12 closely interacts as a co-chaperone. The stability and function of DnaJB12 are contingent on the proper operation of Hsp90, as it assists in the folding and stabilization of client proteins, including DnaJB12 itself. Compounds such as 17-AAG and its derivative, geldanamycin, bind to Hsp90 and disrupt its function, which in turn can lead to the degradation of DnaJB12. Similarly, radicicol and novobiocin, which target Hsp90, can indirectly lead to the functional inhibition of DnaJB12 by destabilizing the chaperone network essential for its activity. Celastrol, known for its Hsp90 inhibitory action, can lead to a cascade of effects culminating in the destabilization of DnaJB12.
Moreover, the inhibitory effect of tanespimycin and alvespimycin on Hsp90 can reverberate through the chaperone machinery, leading to the functional inhibition of DnaJB12. Luminespib, BIIB021, and ganetespib exert their inhibitory effects on Hsp90, which can be expected to disrupt the stability and function of DnaJB12 due to their interdependent relationship. Lastly, onalespib, by selectively inhibiting Hsp90, targets the chaperone network that is critical for maintaining the functional integrity of DnaJB12. Through these mechanisms, the selected chemicals, by acting on Hsp90, exert an indirect yet functional inhibitory effect on DnaJB12. The inhibition of Hsp90, a pivotal player in protein folding and stabilization, is thus a strategic point of interference to inhibit the function of DnaJB12, which relies on the chaperone for its stability and activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG, a Hsp90 inhibitor, could disrupt the function of DnaJB12 by inhibiting Hsp90, which is crucial for the stability and function of many client proteins, including co-chaperones such as DnaJB12. Inhibition of Hsp90 leads to the degradation of client proteins. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90, potentially leading to the destabilization of its client proteins. Since DnaJB12 functions as a co-chaperone to Hsp90, its functional stability can be compromised by geldanamycin. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Radicicol acts as an inhibitor to Hsp90, potentially impacting the stability and function of its co-chaperones, including DnaJB12. This would result in a functional inhibition of DnaJB12 as it relies on Hsp90 for proper function. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin is an Hsp90 C-terminal inhibitor which can disrupt the chaperone function of Hsp90, indirectly affecting DnaJB12 function because of their co-chaperone relationship. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Withaferin A is known to bind to Hsp90 and disrupt its chaperone activity. By doing so, it can indirectly inhibit the functional activity of DnaJB12, which relies on Hsp90. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol is a recognized inhibitor of Hsp90, and its inhibition can lead to the destabilization of DnaJB12, which functions in conjunction with Hsp90. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
Luminespib is an Hsp90 inhibitor that would destabilize co-chaperone proteins including DnaJB12, leading to their functional inhibition. | ||||||
BIIB 021 | 848695-25-0 | sc-364434 sc-364434A | 5 mg 25 mg | $128.00 $650.00 | ||
BIIB021, an oral Hsp90 inhibitor, could indirectly inhibit DnaJB12 by destabilizing the chaperone complex it is part of. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $273.00 $1040.00 | ||
Ganetespib, by inhibiting Hsp90, would lead to a decrease in the functional stability of DnaJB12 as it acts as a co-chaperone to Hsp90. | ||||||
AT13387 | 912999-49-6 | sc-364415 sc-364415A | 10 mg 50 mg | $555.00 $1606.00 | ||
Onalespib selectively inhibits Hsp90, which may result in the functional inhibition of DnaJB12, due to their interdependent relationship within the chaperone machinery. | ||||||